374 related articles for article (PubMed ID: 16009173)
21. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
[TBL] [Abstract][Full Text] [Related]
22. Anti-Müllerian hormone concentrations in maternal serum during pregnancy.
La Marca A; Giulini S; Orvieto R; De Leo V; Volpe A
Hum Reprod; 2005 Jun; 20(6):1569-72. PubMed ID: 15734752
[TBL] [Abstract][Full Text] [Related]
23. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
24. Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization.
Fanchin R; Mendez Lozano DH; Frydman N; Gougeon A; di Clemente N; Frydman R; Taieb J
J Clin Endocrinol Metab; 2007 May; 92(5):1796-802. PubMed ID: 17327387
[TBL] [Abstract][Full Text] [Related]
25. Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.
Andersen CY; Byskov AG
J Clin Endocrinol Metab; 2006 Oct; 91(10):4064-9. PubMed ID: 16895952
[TBL] [Abstract][Full Text] [Related]
26. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
27. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
[TBL] [Abstract][Full Text] [Related]
28. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
[TBL] [Abstract][Full Text] [Related]
30. Regulation of anti-Müllerian hormone production in the cow: a multiscale study at endocrine, ovarian, follicular, and granulosa cell levels.
Rico C; Médigue C; Fabre S; Jarrier P; Bontoux M; Clément F; Monniaux D
Biol Reprod; 2011 Mar; 84(3):560-71. PubMed ID: 21076084
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.
Fanchin R; Méndez Lozano DH; Louafi N; Achour-Frydman N; Frydman R; Taieb J
Hum Reprod; 2005 Mar; 20(3):747-51. PubMed ID: 15618255
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.
Fleming R; Deshpande N; Traynor I; Yates RW
Hum Reprod; 2006 Jun; 21(6):1436-41. PubMed ID: 16439501
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
34. [The anti-mullerian hormone--physiology and application into clinical practice].
Robeva R; Mekhandzhiev Ts; Tomova A; Kumanov F
Akush Ginekol (Sofiia); 2006; 45(7):50-4. PubMed ID: 17489169
[TBL] [Abstract][Full Text] [Related]
35. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
36. Serum anti-Müllerian hormone expression in women with premature ovarian failure.
Méduri G; Massin N; Guibourdenche J; Bachelot A; Fiori O; Kuttenn F; Misrahi M; Touraine P
Hum Reprod; 2007 Jan; 22(1):117-23. PubMed ID: 16954410
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.
Xu J; Bishop CV; Lawson MS; Park BS; Xu F
Hum Reprod; 2016 Jul; 31(7):1522-30. PubMed ID: 27165618
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles.
Andersen CY; Schmidt KT; Kristensen SG; Rosendahl M; Byskov AG; Ernst E
Hum Reprod; 2010 May; 25(5):1282-7. PubMed ID: 20228388
[TBL] [Abstract][Full Text] [Related]
39. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Hum Reprod; 2010 Oct; 25(10):2597-604. PubMed ID: 20729237
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
